CSPC has a very strong financial position. As of 2024, its total debt outstanding is only 5.8% of its total cash in hand. Its annual capital expenditure for 2024 was CNY 2.1 billion.

The second, he said, at the Morris Foreman wastewater plant has been around for 20 years. Barker, for his part, doesn't question the project, just its location. "I do think there is a place for it but ...

Chinese health authorities approved CSPC Pharmaceuticals Group Ltd's (OTC: CSPCY) messenger RNA (mRNA) COVID-19 vaccine for emergency use authorization.

CSPC has a very strong financial position. As of 2022, its total debt outstanding is only 1.8% of its total cash in hand. Its annual capital expenditure for 2022 was CNY 1.8 billion.

The Jungle Room Plant Co. celebrated the move to its new location at 2232 Washington Blvd. on Friday, May 3, 2024. The Jungle Room Plant Co. storefront, photographed Friday, May 3, 2024.

CMB International Securities analyst Jill Wu maintained a Buy rating on CSPC Pharmaceutical Group (CHJTF – Research Report) on August 23 and set a price target of HK$6.21. Jill Wu’s rating is ...

Dividend paying stocks like CSPC Pharmaceutical Group Limited (HKG:1093) tend to be popular with investors, and for good reason - some research suggests a significant amount of all stock market ...

China has approved its first domestically developed mRNA vaccine against COVID-19, CSPC Pharmaceutical Group Ltd said on Wednesday, a major achievement in a country that has declined to use ...

Cambridge, UK-based AstraZeneca will pay CSPC an upfront fee of $110 million. The Hong Kong-listed firm is also eligible to receive up to $1.62 billion in development milestones and $3.6 billion ...

Corbus Pharmaceuticals Holdings Inc. signed a back end-loaded licensing deal worth up to $692.5 million with CSPC Megalith Biopharmaceutical Co. Ltd, a subsidiary of CSPC Pharmaceutical Group Ltd., ...